Attached files
| file | filename |
|---|---|
| EX-99.A - EXHIBIT 99A - MERA PHARMACEUTICALS INC | e3086_ex99a.htm |
| 8-K - FORM 8-K - MERA PHARMACEUTICALS INC | e3086_8-k.htm |
EXHIBIT 99b
Mera Pharmaceuticals, Inc.
Profit & Loss
November 1, 2020 through September 8, 2021
| Nov 1, ‘20 - Sep 8, 21 | ||||
| Ordinary Income/Expense | ||||
| Expense | ||||
| Corporate Registration/Licensin | 4,734.08 | |||
| Transfer Agent and Filing Fees | 4,155.00 | |||
| Total Expense | 8,889.08 | |||
| Net Ordinary Income | -8,889.08 | |||
| Net Income | -8,889.08 | |||